Ispire's Q3 earnings report reveals massive growth

May.17.2023
Ispire's Q3 earnings report reveals massive growth
Ispire released Q3 2023 financial report with impressive YoY revenue growth of 26.9% and gross profit growth of 51.9%.

On May 16th, Ispire announced the release of their financial report for the third quarter of 2023, ending on March 31st. The company also submitted their 10-Q quarterly report to the US Securities and Exchange Commission (SEC) on May 15th. According to the report, Ispire saw a year-over-year revenue growth of 26.9%, reaching $24.1 million in the third quarter, while their gross profit increased by 51.9% to $4.5 million.


It's worth noting that the company's fiscal year end is on June 30, 2023, and they have not chosen December 31 as their fiscal year end date.


Rise in Cannabis Smoking Accessories Sales is a Popular Betting Trend


Michael Wang, the Chief Financial Officer of Ispire, has stated that the company is expecting a continuous revenue growth of 58% to 98% in the fourth quarter of their marijuana smoking devices products.


He added:


We are focused on a multi-pronged strategy aimed at increasing sales of our electronic cigarette products and developing CBD vaporization products with an emphasis on medical and recreational use.


Third Quarter Performance: Tobacco vaporization remains the main product.


In the third quarter of 2023, Ispire recorded a year-on-year revenue growth of 26.9%, reaching $24.1 million. The revenue contribution of electronic cigarette products was $16.5 million, while that of CBD-related vaporizer products was $7.6 million. Gross profit grew 51.9% year-on-year to $4.5 million. However, total operating expenses increased by 106.2% YoY, reaching $8 million compared to $3.9 million in the same period of 2022. Net loss amounted to $3.1 million, whereas in the same period of 2022, the net loss was $1 million.


Looking ahead to the future.


Ispire has provided a projection for its CBD vaporization products for the fourth quarter of 2023 (ending June 30, 2023). The company began marketing CBD vaporization products in mid-2020, with revenue reaching $7.6 million in the third quarter of 2023. It is expected that the revenue in the fourth quarter of 2023 for CBD vaporization products will increase by 58% to 98% compared to the third quarter, with projected revenue ranging between $12 million to $15 million.


According to reports, Ispire is a company that specializes in research and development, design, commercialization, sales, promotion, and distribution of branded electronic cigarettes and CBD vaporization products. The company's tobacco electronic cigarette products are sold under the Aspire brand name.


References:


Ispire Technology Inc. has released its financial results for the third quarter of 2023.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

Jincheng Pharm Expands E-cigarette Business with Export Qualification
Jincheng Pharm Expands E-cigarette Business with Export Qualification
Jincheng Pharm, a Shenzhen-listed company, announced on August 24th that its nicotine synthesis can be exported. The company has the necessary qualifications.
Aug.24 by 2FIRSTS.ai
U.S. Shisha E-Cigarette Market Showdown: AL FAKHER vs. JNR Brand Product Feature Face-off
U.S. Shisha E-Cigarette Market Showdown: AL FAKHER vs. JNR Brand Product Feature Face-off
2FIRSTS discovers new shish e-cigarette products entering the US market, sparking industry attention. Key players include AL FAKHER and JNR.
Market
Aug.20 by 2FIRSTS, edited by Sophia Lv
Total Views Surpass Historical Records, 2FIRSTS Inter-Tabac Exhibition Coverage Concludes Successfully
Total Views Surpass Historical Records, 2FIRSTS Inter-Tabac Exhibition Coverage Concludes Successfully
The Inter-Tabac trade fair concluded on September 21st, with 2FIRSTS, the official media partner, delivering in-depth coverage for the third year running. Our exclusive interviews with international tobacco companies led to record-breaking traffic.
Oct.14 by 2FIRSTS.ai
Dick Durbin Expresses Disappointment Over FDA Approval of Menthol-Flavored E-Cigarettes
Dick Durbin Expresses Disappointment Over FDA Approval of Menthol-Flavored E-Cigarettes
Senate Judiciary Committee Chairman Dick Durbin expressed disappointment in FDA approval of menthol e-cigarette products, citing concerns over youth addiction.
Regulations
Jun.26 by 2FIRSTS.ai
Bangkok Public Health Office Concerned about Lack of Protective Measures for E-cigarettes, Marijuana
Bangkok Public Health Office Concerned about Lack of Protective Measures for E-cigarettes, Marijuana
Bangkok Public Health Office (PSOB) expresses concern over the lack of protective measures for e-cigarettes, marijuana, and kratom in educational and medical institutions.
Regulations
Jan.23 by 2FIRSTS.ai
Russian Parliament Considers Ban on Tobacco Sales near Dormitories
Russian Parliament Considers Ban on Tobacco Sales near Dormitories
Russian Duma parties propose new law to ban tobacco sales near student dorms within 100 meters - Osnmedia reports.
Dec.13 by 2FIRSTS.ai